◀ Back to BCR

BCR — POLDIP2

Text-mined interactions from Literome

Swart et al., J Immunol 2000 (Lymphoma, B-Cell...) : The activity of p38 mitogen activated protein kinase ( MAPK ) was increased in response to BCR ligation
Swart et al., Biochem Biophys Res Commun 2000 : By contrast, we show that pretreatment of CH31 B cells with the highly specific p38 MAPK inhibitor SB203580 ablated both BCR induced p38 MAPK activity and apoptosis
Wu et al., J Immunol 2001 (Severe Combined Immunodeficiency) : Thus, CD72 and BCR activated the extracellular signal regulated kinase ( ERK ) and the c-Jun N-terminal kinase (JNK) but not p38 mitogen activated protein kinase
Niiro et al., J Exp Med 2002 (Calcium Signaling) : Moreover, BCR induced activation of extracellular signal regulated kinase ( ERK ), c-jun NH2-terminal kinase ( JNK ), and p38 mitogen activated protein kinase ( MAPK ) pathways was impaired in Bam32 ( -/- ) cells but not the activation of Akt related pathways
Lee et al., Journal of cell communication and signaling 2007 : In contrast, BCR induced activation of ERK, JNK, p38 , and Akt was not affected by ROS depletion
Ha et al., J Leukoc Biol 2008 : We found that in CB B cells activation of extracellular signal regulated kinase ( ERK ) and p38 following ligation of CD40 but not of the B-cell antigen receptor (BCR) was inefficient
Jiang et al., J Exp Med 1998 : In contrast, BCR mediated p38 MAPK activation was detected in all three PTK-deficient cells, suggesting that no single PTK is essential